nodes	percent_of_prediction	percent_of_DWPC	metapath
Metyrapone—ABCC3—Doxorubicin—ovarian cancer	0.339	0.516	CbGbCtD
Metyrapone—CYP3A4—Topotecan—ovarian cancer	0.113	0.172	CbGbCtD
Metyrapone—CYP3A4—Vinorelbine—ovarian cancer	0.0794	0.121	CbGbCtD
Metyrapone—CYP3A4—Paclitaxel—ovarian cancer	0.0558	0.0849	CbGbCtD
Metyrapone—CYP3A4—Docetaxel—ovarian cancer	0.0403	0.0614	CbGbCtD
Metyrapone—CYP3A4—Doxorubicin—ovarian cancer	0.0301	0.0458	CbGbCtD
Metyrapone—Pancytopenia—Altretamine—ovarian cancer	0.0152	0.0484	CcSEcCtD
Metyrapone—Dermatitis atopic—Chlorambucil—ovarian cancer	0.0122	0.039	CcSEcCtD
Metyrapone—Bone marrow depression—Melphalan—ovarian cancer	0.0117	0.0373	CcSEcCtD
Metyrapone—Dermatitis atopic—Melphalan—ovarian cancer	0.0107	0.034	CcSEcCtD
Metyrapone—Bone marrow depression—Vinorelbine—ovarian cancer	0.0102	0.0326	CcSEcCtD
Metyrapone—Endocrine disorder—Vinorelbine—ovarian cancer	0.00832	0.0265	CcSEcCtD
Metyrapone—Dermatitis atopic—Paclitaxel—ovarian cancer	0.00627	0.02	CcSEcCtD
Metyrapone—Dizziness—Altretamine—ovarian cancer	0.00601	0.0192	CcSEcCtD
Metyrapone—Vomiting—Altretamine—ovarian cancer	0.00578	0.0184	CcSEcCtD
Metyrapone—Nausea—Altretamine—ovarian cancer	0.0054	0.0172	CcSEcCtD
Metyrapone—Pancytopenia—Chlorambucil—ovarian cancer	0.0054	0.0172	CcSEcCtD
Metyrapone—Pain—Carboplatin—ovarian cancer	0.00537	0.0171	CcSEcCtD
Metyrapone—Dermatitis atopic—Docetaxel—ovarian cancer	0.00531	0.0169	CcSEcCtD
Metyrapone—Pancytopenia—Topotecan—ovarian cancer	0.0048	0.0153	CcSEcCtD
Metyrapone—Pancytopenia—Melphalan—ovarian cancer	0.0047	0.015	CcSEcCtD
Metyrapone—Pancytopenia—Vinorelbine—ovarian cancer	0.00411	0.0131	CcSEcCtD
Metyrapone—Alopecia—Chlorambucil—ovarian cancer	0.00402	0.0128	CcSEcCtD
Metyrapone—Bone marrow depression—Epirubicin—ovarian cancer	0.00393	0.0125	CcSEcCtD
Metyrapone—Angiopathy—Topotecan—ovarian cancer	0.00367	0.0117	CcSEcCtD
Metyrapone—Bone marrow depression—Doxorubicin—ovarian cancer	0.00363	0.0116	CcSEcCtD
Metyrapone—Dermatitis atopic—Epirubicin—ovarian cancer	0.00358	0.0114	CcSEcCtD
Metyrapone—Alopecia—Topotecan—ovarian cancer	0.00358	0.0114	CcSEcCtD
Metyrapone—Alopecia—Melphalan—ovarian cancer	0.0035	0.0112	CcSEcCtD
Metyrapone—Dermatitis atopic—Doxorubicin—ovarian cancer	0.00331	0.0106	CcSEcCtD
Metyrapone—Angiopathy—Vinorelbine—ovarian cancer	0.00314	0.01	CcSEcCtD
Metyrapone—Alopecia—Vinorelbine—ovarian cancer	0.00306	0.00976	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.00298	0.0095	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.00292	0.00931	CcSEcCtD
Metyrapone—Nervous system disorder—Topotecan—ovarian cancer	0.00282	0.009	CcSEcCtD
Metyrapone—Skin disorder—Topotecan—ovarian cancer	0.00279	0.00891	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00279	0.0089	CcSEcCtD
Metyrapone—Pancytopenia—Paclitaxel—ovarian cancer	0.00276	0.00882	CcSEcCtD
Metyrapone—Pain—Chlorambucil—ovarian cancer	0.00276	0.00881	CcSEcCtD
Metyrapone—Skin disorder—Melphalan—ovarian cancer	0.00274	0.00873	CcSEcCtD
Metyrapone—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00264	0.00843	CcSEcCtD
Metyrapone—Hypotension—Melphalan—ovarian cancer	0.00263	0.00839	CcSEcCtD
Metyrapone—Hypertension—Vinorelbine—ovarian cancer	0.0026	0.0083	CcSEcCtD
Metyrapone—Abdominal pain—Chlorambucil—ovarian cancer	0.00255	0.00815	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.00255	0.00813	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00248	0.00792	CcSEcCtD
Metyrapone—Pain—Topotecan—ovarian cancer	0.00246	0.00785	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00243	0.00776	CcSEcCtD
Metyrapone—Nervous system disorder—Vinorelbine—ovarian cancer	0.00241	0.0077	CcSEcCtD
Metyrapone—Pain—Melphalan—ovarian cancer	0.00241	0.00768	CcSEcCtD
Metyrapone—Skin disorder—Vinorelbine—ovarian cancer	0.00239	0.00762	CcSEcCtD
Metyrapone—Gastrointestinal pain—Topotecan—ovarian cancer	0.00235	0.0075	CcSEcCtD
Metyrapone—Pancytopenia—Docetaxel—ovarian cancer	0.00234	0.00747	CcSEcCtD
Metyrapone—Hypotension—Vinorelbine—ovarian cancer	0.0023	0.00733	CcSEcCtD
Metyrapone—Abdominal pain—Topotecan—ovarian cancer	0.00227	0.00725	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00212	0.00678	CcSEcCtD
Metyrapone—Angiopathy—Paclitaxel—ovarian cancer	0.00211	0.00674	CcSEcCtD
Metyrapone—Pain—Vinorelbine—ovarian cancer	0.0021	0.00671	CcSEcCtD
Metyrapone—Alopecia—Paclitaxel—ovarian cancer	0.00206	0.00657	CcSEcCtD
Metyrapone—Vomiting—Chlorambucil—ovarian cancer	0.00205	0.00655	CcSEcCtD
Metyrapone—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00201	0.00642	CcSEcCtD
Metyrapone—Abdominal pain—Vinorelbine—ovarian cancer	0.00194	0.0062	CcSEcCtD
Metyrapone—Nausea—Chlorambucil—ovarian cancer	0.00192	0.00612	CcSEcCtD
Metyrapone—Dizziness—Topotecan—ovarian cancer	0.0019	0.00607	CcSEcCtD
Metyrapone—Vomiting—Topotecan—ovarian cancer	0.00183	0.00583	CcSEcCtD
Metyrapone—ABCC3—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	0.0018	0.0608	CbGpPWpGaD
Metyrapone—Headache—Topotecan—ovarian cancer	0.0018	0.00575	CcSEcCtD
Metyrapone—Angiopathy—Docetaxel—ovarian cancer	0.00179	0.00571	CcSEcCtD
Metyrapone—Vomiting—Melphalan—ovarian cancer	0.00179	0.00571	CcSEcCtD
Metyrapone—Hypertension—Paclitaxel—ovarian cancer	0.00175	0.00558	CcSEcCtD
Metyrapone—Alopecia—Docetaxel—ovarian cancer	0.00174	0.00557	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00171	0.00547	CcSEcCtD
Metyrapone—Nausea—Topotecan—ovarian cancer	0.00171	0.00545	CcSEcCtD
Metyrapone—Nausea—Melphalan—ovarian cancer	0.00167	0.00534	CcSEcCtD
Metyrapone—Dizziness—Vinorelbine—ovarian cancer	0.00163	0.00519	CcSEcCtD
Metyrapone—Nervous system disorder—Paclitaxel—ovarian cancer	0.00162	0.00518	CcSEcCtD
Metyrapone—Skin disorder—Paclitaxel—ovarian cancer	0.00161	0.00513	CcSEcCtD
Metyrapone—Pancytopenia—Epirubicin—ovarian cancer	0.00158	0.00504	CcSEcCtD
Metyrapone—Vomiting—Vinorelbine—ovarian cancer	0.00156	0.00499	CcSEcCtD
Metyrapone—Hypotension—Paclitaxel—ovarian cancer	0.00155	0.00493	CcSEcCtD
Metyrapone—Headache—Vinorelbine—ovarian cancer	0.00154	0.00492	CcSEcCtD
Metyrapone—CYP11B2—Endogenous sterols—CYP1B1—ovarian cancer	0.00152	0.0511	CbGpPWpGaD
Metyrapone—Hypertension—Docetaxel—ovarian cancer	0.00148	0.00473	CcSEcCtD
Metyrapone—Pancytopenia—Doxorubicin—ovarian cancer	0.00146	0.00466	CcSEcCtD
Metyrapone—Nausea—Vinorelbine—ovarian cancer	0.00146	0.00466	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00145	0.00464	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00143	0.00456	CcSEcCtD
Metyrapone—Pain—Paclitaxel—ovarian cancer	0.00142	0.00451	CcSEcCtD
Metyrapone—Nervous system disorder—Docetaxel—ovarian cancer	0.00138	0.00439	CcSEcCtD
Metyrapone—Skin disorder—Docetaxel—ovarian cancer	0.00136	0.00435	CcSEcCtD
Metyrapone—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00135	0.00432	CcSEcCtD
Metyrapone—Hypotension—Docetaxel—ovarian cancer	0.00131	0.00418	CcSEcCtD
Metyrapone—Abdominal pain—Paclitaxel—ovarian cancer	0.00131	0.00417	CcSEcCtD
Metyrapone—CYP11B1—Endogenous sterols—CYP1B1—ovarian cancer	0.00131	0.044	CbGpPWpGaD
Metyrapone—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00121	0.00386	CcSEcCtD
Metyrapone—Angiopathy—Epirubicin—ovarian cancer	0.00121	0.00385	CcSEcCtD
Metyrapone—Pain—Docetaxel—ovarian cancer	0.0012	0.00383	CcSEcCtD
Metyrapone—Alopecia—Epirubicin—ovarian cancer	0.00118	0.00375	CcSEcCtD
Metyrapone—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00115	0.00366	CcSEcCtD
Metyrapone—Angiopathy—Doxorubicin—ovarian cancer	0.00112	0.00357	CcSEcCtD
Metyrapone—Abdominal pain—Docetaxel—ovarian cancer	0.00111	0.00354	CcSEcCtD
Metyrapone—Dizziness—Paclitaxel—ovarian cancer	0.00109	0.00349	CcSEcCtD
Metyrapone—Alopecia—Doxorubicin—ovarian cancer	0.00109	0.00347	CcSEcCtD
Metyrapone—Vomiting—Paclitaxel—ovarian cancer	0.00105	0.00336	CcSEcCtD
Metyrapone—Headache—Paclitaxel—ovarian cancer	0.00104	0.00331	CcSEcCtD
Metyrapone—Hypertension—Epirubicin—ovarian cancer	0.001	0.00319	CcSEcCtD
Metyrapone—ABCC3—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	0.000986	0.0332	CbGpPWpGaD
Metyrapone—Nausea—Paclitaxel—ovarian cancer	0.000983	0.00314	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.00098	0.00313	CcSEcCtD
Metyrapone—Nervous system disorder—Epirubicin—ovarian cancer	0.000928	0.00296	CcSEcCtD
Metyrapone—Dizziness—Docetaxel—ovarian cancer	0.000928	0.00296	CcSEcCtD
Metyrapone—Hypertension—Doxorubicin—ovarian cancer	0.000926	0.00295	CcSEcCtD
Metyrapone—Skin disorder—Epirubicin—ovarian cancer	0.000919	0.00293	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000907	0.00289	CcSEcCtD
Metyrapone—Vomiting—Docetaxel—ovarian cancer	0.000892	0.00284	CcSEcCtD
Metyrapone—Hypotension—Epirubicin—ovarian cancer	0.000884	0.00282	CcSEcCtD
Metyrapone—Headache—Docetaxel—ovarian cancer	0.000879	0.0028	CcSEcCtD
Metyrapone—Nervous system disorder—Doxorubicin—ovarian cancer	0.000858	0.00274	CcSEcCtD
Metyrapone—Skin disorder—Doxorubicin—ovarian cancer	0.00085	0.00271	CcSEcCtD
Metyrapone—Nausea—Docetaxel—ovarian cancer	0.000833	0.00266	CcSEcCtD
Metyrapone—Hypotension—Doxorubicin—ovarian cancer	0.000818	0.00261	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000817	0.00261	CcSEcCtD
Metyrapone—Pain—Epirubicin—ovarian cancer	0.000809	0.00258	CcSEcCtD
Metyrapone—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000774	0.00247	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000756	0.00241	CcSEcCtD
Metyrapone—Pain—Doxorubicin—ovarian cancer	0.000749	0.00239	CcSEcCtD
Metyrapone—Abdominal pain—Epirubicin—ovarian cancer	0.000748	0.00239	CcSEcCtD
Metyrapone—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000716	0.00228	CcSEcCtD
Metyrapone—CYP11B2—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000704	0.0237	CbGpPWpGaD
Metyrapone—CYP11B2—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000695	0.0234	CbGpPWpGaD
Metyrapone—Abdominal pain—Doxorubicin—ovarian cancer	0.000692	0.00221	CcSEcCtD
Metyrapone—CYP2A6—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.000634	0.0214	CbGpPWpGaD
Metyrapone—Dizziness—Epirubicin—ovarian cancer	0.000626	0.002	CcSEcCtD
Metyrapone—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000607	0.0204	CbGpPWpGaD
Metyrapone—Vomiting—Epirubicin—ovarian cancer	0.000602	0.00192	CcSEcCtD
Metyrapone—CYP11B1—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000599	0.0202	CbGpPWpGaD
Metyrapone—ABCC3—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000595	0.02	CbGpPWpGaD
Metyrapone—Headache—Epirubicin—ovarian cancer	0.000593	0.00189	CcSEcCtD
Metyrapone—Dizziness—Doxorubicin—ovarian cancer	0.000579	0.00185	CcSEcCtD
Metyrapone—CYP11B2—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000571	0.0192	CbGpPWpGaD
Metyrapone—ABCC3—Fluoropyrimidine Activity—TYMS—ovarian cancer	0.00057	0.0192	CbGpPWpGaD
Metyrapone—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000567	0.0191	CbGpPWpGaD
Metyrapone—Nausea—Epirubicin—ovarian cancer	0.000562	0.00179	CcSEcCtD
Metyrapone—Vomiting—Doxorubicin—ovarian cancer	0.000557	0.00178	CcSEcCtD
Metyrapone—Headache—Doxorubicin—ovarian cancer	0.000548	0.00175	CcSEcCtD
Metyrapone—ABCC3—ABC-family proteins mediated transport—ABCB1—ovarian cancer	0.000541	0.0182	CbGpPWpGaD
Metyrapone—Nausea—Doxorubicin—ovarian cancer	0.00052	0.00166	CcSEcCtD
Metyrapone—CYP2E1—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.000501	0.0169	CbGpPWpGaD
Metyrapone—CYP11B1—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000492	0.0166	CbGpPWpGaD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—PARP1—ovarian cancer	0.000471	0.0159	CbGpPWpGaD
Metyrapone—CYP3A4—Liver X Receptor Pathway—FASN—ovarian cancer	0.000462	0.0156	CbGpPWpGaD
Metyrapone—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—ovarian cancer	0.000458	0.0154	CbGpPWpGaD
Metyrapone—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	0.000414	0.014	CbGpPWpGaD
Metyrapone—CYP2A6—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000373	0.0126	CbGpPWpGaD
Metyrapone—CYP2A6—Fluoropyrimidine Activity—TYMS—ovarian cancer	0.000357	0.012	CbGpPWpGaD
Metyrapone—CYP11B2—Biological oxidations—CYP1B1—ovarian cancer	0.000303	0.0102	CbGpPWpGaD
Metyrapone—CYP11B2—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000299	0.0101	CbGpPWpGaD
Metyrapone—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.00028	0.00945	CbGpPWpGaD
Metyrapone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—ovarian cancer	0.00028	0.00942	CbGpPWpGaD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—TLR4—ovarian cancer	0.000278	0.00936	CbGpPWpGaD
Metyrapone—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000274	0.00922	CbGpPWpGaD
Metyrapone—CYP2A6—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.00027	0.0091	CbGpPWpGaD
Metyrapone—CYP2E1—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000267	0.00901	CbGpPWpGaD
Metyrapone—CYP3A4—Estrogen metabolism—CYP1B1—ovarian cancer	0.000263	0.00886	CbGpPWpGaD
Metyrapone—CYP11B1—Biological oxidations—CYP1B1—ovarian cancer	0.000261	0.0088	CbGpPWpGaD
Metyrapone—CYP11B1—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000258	0.00868	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000234	0.00788	CbGpPWpGaD
Metyrapone—CYP3A4—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.000232	0.00783	CbGpPWpGaD
Metyrapone—ABCC3—NRF2 pathway—SLC5A5—ovarian cancer	0.000232	0.0078	CbGpPWpGaD
Metyrapone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	0.000227	0.00763	CbGpPWpGaD
Metyrapone—ABCC3—NRF2 pathway—SLC2A1—ovarian cancer	0.000224	0.00754	CbGpPWpGaD
Metyrapone—CYP2A6—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000222	0.00747	CbGpPWpGaD
Metyrapone—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000216	0.00729	CbGpPWpGaD
Metyrapone—CYP2E1—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000213	0.00719	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000201	0.00679	CbGpPWpGaD
Metyrapone—CYP3A4—Irinotecan Pathway—APC—ovarian cancer	0.000191	0.00643	CbGpPWpGaD
Metyrapone—ABCC3—Fluoropyrimidine Activity—TP53—ovarian cancer	0.000189	0.00637	CbGpPWpGaD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—CXCL8—ovarian cancer	0.000188	0.00635	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—NME2—ovarian cancer	0.000185	0.00623	CbGpPWpGaD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—CASP3—ovarian cancer	0.00018	0.00607	CbGpPWpGaD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—IL2—ovarian cancer	0.00018	0.00607	CbGpPWpGaD
Metyrapone—CYP2E1—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000175	0.00591	CbGpPWpGaD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—CTNNB1—ovarian cancer	0.000174	0.00586	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—NME2—ovarian cancer	0.000159	0.00537	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000157	0.00528	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000147	0.00494	CbGpPWpGaD
Metyrapone—CYP2A6—NRF2 pathway—SLC5A5—ovarian cancer	0.000145	0.00489	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000145	0.00489	CbGpPWpGaD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—MAPK3—ovarian cancer	0.000145	0.00488	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000141	0.00474	CbGpPWpGaD
Metyrapone—CYP2A6—NRF2 pathway—SLC2A1—ovarian cancer	0.00014	0.00472	CbGpPWpGaD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—MAPK1—ovarian cancer	0.000138	0.00464	CbGpPWpGaD
Metyrapone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000137	0.0046	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000135	0.00455	CbGpPWpGaD
Metyrapone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.00013	0.00439	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000128	0.00431	CbGpPWpGaD
Metyrapone—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000124	0.00418	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—CYTB—ovarian cancer	0.000119	0.00401	CbGpPWpGaD
Metyrapone—CYP2A6—Fluoropyrimidine Activity—TP53—ovarian cancer	0.000118	0.00399	CbGpPWpGaD
Metyrapone—CYP2A6—Biological oxidations—CYP1B1—ovarian cancer	0.000118	0.00397	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000116	0.00392	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—NME2—ovarian cancer	0.000115	0.00386	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000111	0.00375	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.00011	0.00371	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—BRIP1—ovarian cancer	0.000104	0.00351	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PPP1CC—ovarian cancer	0.000104	0.00351	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CYTB—ovarian cancer	0.000103	0.00346	CbGpPWpGaD
Metyrapone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.0001	0.00338	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.0001	0.00338	CbGpPWpGaD
Metyrapone—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	9.9e-05	0.00334	CbGpPWpGaD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—AKT1—ovarian cancer	9.76e-05	0.00329	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	9.73e-05	0.00328	CbGpPWpGaD
Metyrapone—CYP2E1—Biological oxidations—CYP1B1—ovarian cancer	9.31e-05	0.00314	CbGpPWpGaD
Metyrapone—CYP2E1—Metapathway biotransformation—CYP1B1—ovarian cancer	9.18e-05	0.00309	CbGpPWpGaD
Metyrapone—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—ovarian cancer	9.02e-05	0.00304	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—BRIP1—ovarian cancer	8.97e-05	0.00302	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PPP1CC—ovarian cancer	8.97e-05	0.00302	CbGpPWpGaD
Metyrapone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	8.13e-05	0.00274	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	7.93e-05	0.00267	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	7.59e-05	0.00256	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	7.42e-05	0.0025	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CYTB—ovarian cancer	7.39e-05	0.00249	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	7.22e-05	0.00243	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—NME2—ovarian cancer	7.18e-05	0.00242	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	7.16e-05	0.00241	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—YAP1—ovarian cancer	6.98e-05	0.00235	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.91e-05	0.00233	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	6.54e-05	0.0022	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—BRIP1—ovarian cancer	6.46e-05	0.00218	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PPP1CC—ovarian cancer	6.46e-05	0.00218	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.07e-05	0.00205	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—YAP1—ovarian cancer	6.02e-05	0.00203	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.95e-05	0.00201	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—FASN—ovarian cancer	5.69e-05	0.00192	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—NME2—ovarian cancer	5.68e-05	0.00191	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	5.66e-05	0.00191	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—SLC5A5—ovarian cancer	5.6e-05	0.00189	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—SLC2A1—ovarian cancer	5.41e-05	0.00182	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.29e-05	0.00178	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.23e-05	0.00176	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—CYP1B1—ovarian cancer	5.18e-05	0.00175	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—FASN—ovarian cancer	4.9e-05	0.00165	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—SLC5A5—ovarian cancer	4.82e-05	0.00163	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	4.71e-05	0.00159	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—SLC2A1—ovarian cancer	4.66e-05	0.00157	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CYTB—ovarian cancer	4.63e-05	0.00156	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PPP2R1A—ovarian cancer	4.6e-05	0.00155	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.57e-05	0.00154	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.56e-05	0.00154	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CYP1B1—ovarian cancer	4.47e-05	0.00151	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—YAP1—ovarian cancer	4.33e-05	0.00146	CbGpPWpGaD
Metyrapone—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	4.32e-05	0.00146	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.29e-05	0.00144	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—ABCB1—ovarian cancer	4.27e-05	0.00144	CbGpPWpGaD
Metyrapone—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	4.26e-05	0.00144	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—TYMS—ovarian cancer	4.19e-05	0.00141	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—BRIP1—ovarian cancer	4.05e-05	0.00136	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PPP1CC—ovarian cancer	4.05e-05	0.00136	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PPP2R1A—ovarian cancer	3.96e-05	0.00134	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.94e-05	0.00133	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.77e-05	0.00127	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—ABCB1—ovarian cancer	3.68e-05	0.00124	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CYTB—ovarian cancer	3.66e-05	0.00123	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—TYMS—ovarian cancer	3.61e-05	0.00122	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—FASN—ovarian cancer	3.53e-05	0.00119	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—SLC5A5—ovarian cancer	3.47e-05	0.00117	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—CAV1—ovarian cancer	3.38e-05	0.00114	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—SLC2A1—ovarian cancer	3.36e-05	0.00113	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.29e-05	0.00111	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.23e-05	0.00109	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CYP1B1—ovarian cancer	3.22e-05	0.00108	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PPP1CC—ovarian cancer	3.2e-05	0.00108	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—BRIP1—ovarian cancer	3.2e-05	0.00108	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PIK3CG—ovarian cancer	3.08e-05	0.00104	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CAV1—ovarian cancer	2.91e-05	0.000981	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PPP2R1A—ovarian cancer	2.85e-05	0.000961	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.84e-05	0.000957	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.78e-05	0.000937	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—YAP1—ovarian cancer	2.71e-05	0.000915	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PIK3CD—ovarian cancer	2.7e-05	0.000912	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PIK3CG—ovarian cancer	2.65e-05	0.000894	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ABCB1—ovarian cancer	2.65e-05	0.000893	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—NME2—ovarian cancer	2.63e-05	0.000888	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—TYMS—ovarian cancer	2.6e-05	0.000877	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PIK3CB—ovarian cancer	2.36e-05	0.000795	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PIK3CD—ovarian cancer	2.33e-05	0.000786	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—FASN—ovarian cancer	2.21e-05	0.000746	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—SLC5A5—ovarian cancer	2.18e-05	0.000733	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—YAP1—ovarian cancer	2.14e-05	0.000723	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—SLC2A1—ovarian cancer	2.1e-05	0.000708	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CAV1—ovarian cancer	2.1e-05	0.000706	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PTEN—ovarian cancer	2.04e-05	0.000687	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PIK3CB—ovarian cancer	2.03e-05	0.000685	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CYP1B1—ovarian cancer	2.01e-05	0.000679	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2e-05	0.000675	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PIK3CG—ovarian cancer	1.91e-05	0.000643	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PPP2R1A—ovarian cancer	1.79e-05	0.000602	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PTEN—ovarian cancer	1.76e-05	0.000592	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—FASN—ovarian cancer	1.75e-05	0.000589	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—SLC5A5—ovarian cancer	1.72e-05	0.00058	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CYTB—ovarian cancer	1.7e-05	0.000572	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PIK3CD—ovarian cancer	1.68e-05	0.000566	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—SLC2A1—ovarian cancer	1.66e-05	0.00056	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ABCB1—ovarian cancer	1.66e-05	0.000559	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—TYMS—ovarian cancer	1.63e-05	0.000549	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CYP1B1—ovarian cancer	1.59e-05	0.000537	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.48e-05	0.0005	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.48e-05	0.0005	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PIK3CB—ovarian cancer	1.46e-05	0.000493	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PIK3CA—ovarian cancer	1.44e-05	0.000484	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	1.41e-05	0.000476	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CAV1—ovarian cancer	1.31e-05	0.000443	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ABCB1—ovarian cancer	1.31e-05	0.000442	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—TYMS—ovarian cancer	1.29e-05	0.000434	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PTEN—ovarian cancer	1.26e-05	0.000426	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PIK3CA—ovarian cancer	1.24e-05	0.000417	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PIK3CG—ovarian cancer	1.2e-05	0.000403	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—AKT1—ovarian cancer	1.17e-05	0.000396	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PIK3CD—ovarian cancer	1.05e-05	0.000354	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CAV1—ovarian cancer	1.04e-05	0.00035	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—AKT1—ovarian cancer	1.01e-05	0.000341	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—YAP1—ovarian cancer	9.95e-06	0.000335	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PIK3CG—ovarian cancer	9.45e-06	0.000319	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PIK3CB—ovarian cancer	9.16e-06	0.000309	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PIK3CA—ovarian cancer	8.92e-06	0.000301	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PIK3CD—ovarian cancer	8.31e-06	0.00028	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—FASN—ovarian cancer	8.11e-06	0.000273	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SLC5A5—ovarian cancer	7.98e-06	0.000269	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PTEN—ovarian cancer	7.92e-06	0.000267	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SLC2A1—ovarian cancer	7.71e-06	0.00026	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CYP1B1—ovarian cancer	7.39e-06	0.000249	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—AKT1—ovarian cancer	7.29e-06	0.000246	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PIK3CB—ovarian cancer	7.24e-06	0.000244	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	6.55e-06	0.000221	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PTEN—ovarian cancer	6.26e-06	0.000211	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ABCB1—ovarian cancer	6.08e-06	0.000205	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—TYMS—ovarian cancer	5.97e-06	0.000201	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PIK3CA—ovarian cancer	5.59e-06	0.000188	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CAV1—ovarian cancer	4.81e-06	0.000162	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—AKT1—ovarian cancer	4.56e-06	0.000154	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PIK3CA—ovarian cancer	4.42e-06	0.000149	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PIK3CG—ovarian cancer	4.39e-06	0.000148	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PIK3CD—ovarian cancer	3.86e-06	0.00013	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—AKT1—ovarian cancer	3.61e-06	0.000122	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PIK3CB—ovarian cancer	3.36e-06	0.000113	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PTEN—ovarian cancer	2.9e-06	9.78e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PIK3CA—ovarian cancer	2.05e-06	6.9e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—AKT1—ovarian cancer	1.67e-06	5.64e-05	CbGpPWpGaD
